- Home
- BLFS vs BCRX Comparison
BLFS vs BCRX Comparison
Compare BLFS & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLFS | BCRX |
|---|---|---|
| Founded | 1987 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2013 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BLFS | BCRX |
|---|---|---|
| Price | $38.77 | $8.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $31.29 | $20.73 |
| AVG Volume (30 Days) | 856.3K | ★ 5.1M |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 77.27 | ★ 381.40 |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $96,214,000.00 | $25,186,000.00 |
| Revenue This Year | $19.76 | N/A |
| Revenue Next Year | $17.03 | $4.02 |
| P/E Ratio | $39.13 | ★ N/A |
| Revenue Growth | ★ 16.97 | N/A |
| 52 Week Low | $17.86 | $6.00 |
| 52 Week High | $39.76 | $11.22 |
Technical Indicators
Market Signals| Indicator | BLFS | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 59.48 | 37.22 |
| Support Level | $34.38 | $8.04 |
| Resistance Level | N/A | $9.22 |
| Average True Range (ATR) | 1.10 | 0.30 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 72.24 | 21.43 |
Price Performance
Historical ComparisonAbout BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.